Exane BNP Paribas upgraded UBS (UBS) to Outperform from Neutral with a price target of CHF 35, up from CHF 27.50. The firm says market concerns around the impact of a revision to Swiss capital rules are overdone. The release of capital from UBS’s foreign subsidiaries may “neutralize the most threatening element of the proposals,” the analyst tells investors in a research note.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UBS:
- CompoSecure to spin off Resolute, EHang raises Q4 revenue view; Morning Buzz
- UBS CEO says Switzerland should avoid major banking regulations, Reuters says
- UBS CEO Warns Against Switzerland Introducing Strict Banking Regulations
- Swiss lawmakers criticize ‘mismanagement’ at Credit Suisse, FT reports
- Swiss report on Credit Suisse to be published Friday, Reuters reports